LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹3.35 Cr | ₹0.65 Cr | ₹1.82 Cr | ₹2.44 Cr | ₹3.47 Cr |
What is the latest Long Term Provisions ratio of LYKA LABS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹3.35 Cr |
| Mar2025 | ₹0.65 Cr |
| Mar2024 | ₹1.82 Cr |
| Mar2023 | ₹2.44 Cr |
| Mar2022 | ₹3.47 Cr |
How is Long Term Provisions of LYKA LABS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.35 Cr | 414.13 | |
| Mar2025 | ₹0.65 Cr | -64.27 | |
| Mar2024 | ₹1.82 Cr | -25.27 | |
| Mar2023 | ₹2.44 Cr | -29.72 | |
| Mar2022 | ₹3.47 Cr | - | |
Compare Long Term Provisions of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹285.6 Cr | 5.2% | 14.4% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 5.2% |
14.4% |
-21.7% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses